<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01260428</url>
  </required_header>
  <id_info>
    <org_study_id>10-AGIR-2</org_study_id>
    <nct_id>NCT01260428</nct_id>
  </id_info>
  <brief_title>Effects of Expiratory Pressure on Arterial Oxygenation During Hypoxia</brief_title>
  <acronym>hypex</acronym>
  <official_title>Arterial Oxygenation During Hypoxia : Effects of an Added Expiratory Resistance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AGIR à Dom</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AGIR à Dom</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Altitude tolerance correlates with the level of oxygenation achieved. The aim of the present
      study is to investigate whether increased expiratory pressure within the thorax is able to
      improve oxygenation during hypoxic hypoxia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two types of procedures will be tested in a random order, interspaced by resting periods :
      threshold PEEP set at 5,10 and 15 cm of water and pursed leap breathing.

      Subjects will be tested at rest, and during light exercise (30% of sea level predicted
      VO2max).

      FiO2 will be set at 12.5% (4000 m). fc, VE, PETCO2, TA, ECG, cardiac output, and tissular
      oxygenation will be monitored.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SpO2</measure>
    <time_frame>mean over 1 minute</time_frame>
    <description>after three minutes of PEEP vs spontaneous breathing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>peripheral HbO2/DeoxyHb</measure>
    <time_frame>1 min</time_frame>
    <description>after three minutes of PEEP / PLB vs. spontaneous breathing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac output</measure>
    <time_frame>mean over 1 min</time_frame>
    <description>after three min of PEEP vs. spontaneous breathing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pattern of breathing (fR, VT, PETCO2)</measure>
    <time_frame>1 min</time_frame>
    <description>after three min of PEEP vs. spontaneous breathing</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hypoxia</condition>
  <arm_group>
    <arm_group_label>healthy active subjects</arm_group_label>
    <description>with and without high altitude intolerance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>threshold PEEP</intervention_name>
    <description>Various set of pressures : 0, 5, 10 cm H20; pursed lips breathing</description>
    <arm_group_label>healthy active subjects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        community sample with mounteneering experience
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria :

          -  active (&gt; 2 hrs/week physical activity)

          -  adult

          -  non smoking volunteers

        Exclusion Criteria :

          -  cardiac, respiratory, neuromuscular, metabolic pathology
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard Wuyam, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Samuel Vergès, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hugo NESPOULET, MsC</last_name>
    <role>Study Chair</role>
    <affiliation>Université Joseph Fourier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bernard Wuyam, MD, PhD</last_name>
    <phone>33 (0)4 76 76 93 03</phone>
    <email>BWuyam@chu-grenoble.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>La Tronche</city>
        <state>Isere</state>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BERNARD WUYAM, MD? PhD</last_name>
      <phone>(33) 04 76 76 93 03</phone>
      <email>BWuyam@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>hugo nespoulet, Bsc</last_name>
      <phone>04 76 76 55 16</phone>
      <email>HNespoulet@chu-grenoble.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Bernard Wuyam, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samuel Vergès, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2010</study_first_submitted>
  <study_first_submitted_qc>December 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2010</study_first_posted>
  <last_update_submitted>February 27, 2012</last_update_submitted>
  <last_update_submitted_qc>February 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hypoxia</keyword>
  <keyword>O2 diffusion and convection</keyword>
  <keyword>cardiac output</keyword>
  <keyword>PEEP</keyword>
  <keyword>Effects of hypoxia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

